Actinium Pharmaceuticals IncNYSE American:ATNM
- LAST PRICE1.8000
- TODAY'S CHANGE (%)-0.0800 (-4.2553%)
- Bid / Lots1.7900/ 4
- Ask / Lots1.8800/ 2
- Open / Previous Close1.9000 / 1.8800
- Day Range
- 52 Week Range
- Volume496,991
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATNM |
|---|---|---|
| 09:32 ET | 55298 | 1.8978 |
| 09:34 ET | 3180 | 1.88 |
| 09:39 ET | 1375 | 1.91 |
| 09:41 ET | 100 | 1.85 |
| 09:48 ET | 526 | 1.85 |
| 09:52 ET | 352 | 1.875 |
| 09:54 ET | 152 | 1.8949 |
| 09:56 ET | 200 | 1.89 |
| 09:57 ET | 200 | 1.89 |
| 09:59 ET | 400 | 1.885 |
| 10:01 ET | 188 | 1.8751 |
| 10:03 ET | 800 | 1.875 |
| 10:06 ET | 100 | 1.875 |
| 10:08 ET | 502 | 1.865 |
| 10:10 ET | 3384 | 1.87 |
| 10:12 ET | 2273 | 1.85 |
| 10:14 ET | 600 | 1.86 |
| 10:19 ET | 901 | 1.875 |
| 10:26 ET | 100 | 1.88 |
| 10:28 ET | 400 | 1.885 |
| 10:30 ET | 200 | 1.885 |
| 10:33 ET | 400 | 1.89 |
| 10:35 ET | 100 | 1.88 |
| 10:37 ET | 600 | 1.885 |
| 10:42 ET | 1100 | 1.895 |
| 10:44 ET | 300 | 1.9 |
| 10:46 ET | 300 | 1.8908 |
| 10:48 ET | 2600 | 1.87 |
| 10:50 ET | 2500 | 1.87 |
| 10:51 ET | 3000 | 1.8631 |
| 10:55 ET | 100 | 1.88 |
| 10:57 ET | 3400 | 1.88 |
| 11:02 ET | 1445 | 1.8601 |
| 11:04 ET | 2265 | 1.84 |
| 11:06 ET | 743 | 1.85 |
| 11:08 ET | 900 | 1.86 |
| 11:11 ET | 400 | 1.86 |
| 11:13 ET | 100 | 1.86 |
| 11:15 ET | 100 | 1.86 |
| 11:18 ET | 1075 | 1.86 |
| 11:20 ET | 700 | 1.865 |
| 11:22 ET | 800 | 1.8606 |
| 11:26 ET | 1767 | 1.85 |
| 11:27 ET | 100 | 1.85 |
| 11:29 ET | 200 | 1.8678 |
| 11:33 ET | 3318 | 1.835 |
| 11:36 ET | 300 | 1.835 |
| 11:38 ET | 4093 | 1.83 |
| 11:40 ET | 400 | 1.835 |
| 11:42 ET | 100 | 1.835 |
| 11:44 ET | 100 | 1.835 |
| 11:45 ET | 200 | 1.835 |
| 11:47 ET | 1749 | 1.83 |
| 11:49 ET | 695 | 1.82 |
| 11:51 ET | 200 | 1.825 |
| 11:54 ET | 401 | 1.8299 |
| 11:56 ET | 100 | 1.82 |
| 12:00 ET | 100 | 1.82 |
| 12:02 ET | 320 | 1.83 |
| 12:05 ET | 100 | 1.825 |
| 12:07 ET | 200 | 1.825 |
| 12:09 ET | 150 | 1.8214 |
| 12:12 ET | 100 | 1.825 |
| 12:14 ET | 209 | 1.8297 |
| 12:18 ET | 100 | 1.825 |
| 12:21 ET | 100 | 1.825 |
| 12:25 ET | 747 | 1.82 |
| 12:30 ET | 4023 | 1.82 |
| 12:32 ET | 8809 | 1.805 |
| 12:36 ET | 400 | 1.8 |
| 12:38 ET | 164 | 1.8097 |
| 12:41 ET | 200 | 1.805 |
| 12:43 ET | 1591 | 1.8094 |
| 12:45 ET | 300 | 1.81 |
| 12:48 ET | 150 | 1.8149 |
| 12:50 ET | 201 | 1.81 |
| 12:52 ET | 2404 | 1.8199 |
| 12:54 ET | 2099 | 1.8309 |
| 12:56 ET | 100 | 1.84 |
| 12:57 ET | 1191 | 1.8306 |
| 12:59 ET | 600 | 1.845 |
| 01:01 ET | 389 | 1.83 |
| 01:06 ET | 1200 | 1.84 |
| 01:08 ET | 100 | 1.84 |
| 01:12 ET | 182 | 1.84 |
| 01:14 ET | 1018 | 1.86 |
| 01:15 ET | 660 | 1.86 |
| 01:17 ET | 500 | 1.86 |
| 01:19 ET | 200 | 1.86 |
| 01:21 ET | 2400 | 1.85 |
| 01:24 ET | 500 | 1.84 |
| 01:26 ET | 300 | 1.84 |
| 01:28 ET | 300 | 1.84 |
| 01:30 ET | 1195 | 1.84 |
| 01:32 ET | 500 | 1.85 |
| 01:33 ET | 671 | 1.855 |
| 01:35 ET | 300 | 1.86 |
| 01:37 ET | 3556 | 1.85 |
| 01:39 ET | 300 | 1.86 |
| 01:42 ET | 500 | 1.86 |
| 01:44 ET | 300 | 1.86 |
| 01:46 ET | 912 | 1.8539 |
| 01:48 ET | 600 | 1.86 |
| 01:50 ET | 600 | 1.85 |
| 01:51 ET | 300 | 1.85 |
| 01:53 ET | 500 | 1.86 |
| 01:55 ET | 300 | 1.86 |
| 01:57 ET | 807 | 1.8594 |
| 02:00 ET | 300 | 1.87 |
| 02:02 ET | 4771 | 1.8582 |
| 02:04 ET | 1565 | 1.86 |
| 02:06 ET | 2831 | 1.85 |
| 02:08 ET | 400 | 1.86 |
| 02:09 ET | 700 | 1.86 |
| 02:11 ET | 500 | 1.86 |
| 02:13 ET | 600 | 1.87 |
| 02:15 ET | 300 | 1.865 |
| 02:18 ET | 300 | 1.87 |
| 02:20 ET | 1000 | 1.86 |
| 02:22 ET | 1200 | 1.86 |
| 02:24 ET | 200 | 1.865 |
| 02:26 ET | 500 | 1.865 |
| 02:27 ET | 300 | 1.87 |
| 02:29 ET | 400 | 1.87 |
| 02:31 ET | 400 | 1.87 |
| 02:33 ET | 526 | 1.87 |
| 02:36 ET | 3251 | 1.87 |
| 02:38 ET | 1288 | 1.87 |
| 02:40 ET | 1724 | 1.8725 |
| 02:42 ET | 873 | 1.87 |
| 02:44 ET | 200 | 1.87 |
| 02:45 ET | 300 | 1.88 |
| 02:47 ET | 771 | 1.89 |
| 02:49 ET | 400 | 1.8864 |
| 02:51 ET | 1500 | 1.885 |
| 02:54 ET | 2490 | 1.875 |
| 02:56 ET | 300 | 1.88 |
| 02:58 ET | 448 | 1.88 |
| 03:00 ET | 500 | 1.88 |
| 03:02 ET | 1510 | 1.88 |
| 03:03 ET | 3407 | 1.88 |
| 03:05 ET | 3190 | 1.864 |
| 03:07 ET | 600 | 1.87 |
| 03:09 ET | 1000 | 1.88 |
| 03:12 ET | 700 | 1.88 |
| 03:14 ET | 2125 | 1.88 |
| 03:16 ET | 1069 | 1.88 |
| 03:18 ET | 3635 | 1.86 |
| 03:20 ET | 200 | 1.86 |
| 03:21 ET | 100 | 1.86 |
| 03:23 ET | 300 | 1.86 |
| 03:25 ET | 106 | 1.86 |
| 03:27 ET | 400 | 1.86 |
| 03:30 ET | 1877 | 1.86 |
| 03:32 ET | 300 | 1.87 |
| 03:34 ET | 1092 | 1.855 |
| 03:36 ET | 122 | 1.86 |
| 03:38 ET | 300 | 1.86 |
| 03:39 ET | 650 | 1.86 |
| 03:41 ET | 8503 | 1.84 |
| 03:43 ET | 1700 | 1.83 |
| 03:45 ET | 700 | 1.83 |
| 03:48 ET | 4966 | 1.83 |
| 03:50 ET | 1400 | 1.825 |
| 03:52 ET | 6819 | 1.81 |
| 03:54 ET | 4162 | 1.8 |
| 03:56 ET | 452 | 1.795 |
| 03:57 ET | 46243 | 1.795 |
| 03:59 ET | 120925 | 1.8 |
Yesterday
Actinium Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Encourages Impacted Shareholders To Reach Out, from 16 hours ago by Dow Jones
16 hours ago by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM, from 17 hours ago by Dow Jones
17 hours ago by Dow Jones
Sep 20, 2024
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud, from 11:04AM ET on Friday Sep 20, 2024 by Dow Jones
11:04AM ET on Friday Sep 20, 2024 by Dow JonesActinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology, from 8:00AM ET on Friday Sep 20, 2024 by Dow Jones
8:00AM ET on Friday Sep 20, 2024 by Dow Jones
Sep 19, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM, from 7:46PM ET on Thursday Sep 19, 2024 by Dow Jones
7:46PM ET on Thursday Sep 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Actinium Pharmaceuticals Inc | 56.1M | -1.2x | --- |
Aerovate Therapeutics Inc | 54.8M | -0.6x | --- |
Elicio Therapeutics Inc | 54.6M | -1.0x | --- |
Mural Oncology PLC | 57.6M | -0.3x | --- |
CalciMedica Inc | 53.6M | -2.7x | --- |
Intensity Therapeutics Inc | 53.4M | -3.5x | --- |
Company Information
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A is a therapeutic agent, have demonstrated potential to extend survival outcomes for people with relapsed and refractory acute myeloid leukemia. The Company focuses on advance Iomab-B for other blood cancers and next generation conditioning candidate Iomab-ACT to improve cell and gene therapy outcomes. The Company holds patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron. Actinium-225 is a potent alpha-particle emitter that has high linear energy transfer capable of killing targeted cancer cells via double-strand breaks in DNA.
Contact Information
- Headquarters
- 100 Park Ave., 23Rd FloorNEW YORK, NY, United States 10017
- Phone
- 646-677-3870
- Fax
- 845-818-3588
Executives
- Chairman of the Board, Chief Executive Officer
- Sandesh Seth
- Chief Financial Officer
- Steve O'Loughlin
- Chief Business Officer
- Lynn Bodarky
- Independent Director
- Jeffrey Chell
- Lead Independent Director
- C. David Nicholson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $56.1M |
|---|---|
Revenue (TTM) | $81.0K |
Shares Outstanding | 31.2M |
Actinium Pharmaceuticals Inc does not pay a dividend. | |
Beta | 0.15 |
EPS | $-1.52 |
Book Value | $1.32 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 692.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57,665.43% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
